Single anastomosis sleeve ileal bypass
Single anastomosis sleeve ileal bypass has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Nov 18, 2026: “Single-center experience with sasi bypass: mid-term outcomes and technical evolution”.
1 paper studies it5 findingsUpdated
1 new paper in 30 daysSee all 1 papers on single anastomosis sleeve ileal bypass
At a glance
The findings reach people, from one lab or study. 1 lab.
“Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”
None of its findings points the other way.
- 1 lab
- Humans1
What did studies of single anastomosis sleeve ileal bypass find?
5Studies of single anastomosis sleeve ileal bypass measured 5 outcomes, among them gastroesophageal reflux disease symptoms, dyslipidemia and hypertension.
Gastroesophageal reflux disease symptoms
downin humans1
1 study
Gastroesophageal reflux disease symptoms
downin humans1
Single anastomosis sleeve ileal bypass is linked with lower gastroesophageal reflux disease symptoms in humans (Patients affected by GERD) (Improvement in all affected patients; 57.9% complete remission).
“GERD symptoms improved in all affected patients, with 57.9% achieving complete remission.”
HumansPatients affected by GERD
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
Langenbeck's archives of surgery
Dyslipidemia
downin humans1−86% remission
1 study
Dyslipidemia
downin humans1−86% remission
Single anastomosis sleeve ileal bypass is linked with lower dyslipidemia in humans (Primary metabolic and bariatric surgery) (85.6% remission).
“Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”
HumansPrimary metabolic and bariatric surgery
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
Langenbeck's archives of surgery
Hypertension
downin humans1−89% remission
1 study
Hypertension
downin humans1−89% remission
Single anastomosis sleeve ileal bypass is linked with lower hypertension in humans (Primary metabolic and bariatric surgery) (89.1% remission).
“Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”
HumansPrimary metabolic and bariatric surgery
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
Langenbeck's archives of surgery
Type 2 diabetes
downin humans1−78% remission
1 study
Type 2 diabetes
downin humans1−78% remission
Single anastomosis sleeve ileal bypass is linked with lower type 2 diabetes in humans (Primary metabolic and bariatric surgery) (78.3% remission).
“Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”
HumansPrimary metabolic and bariatric surgery
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
Langenbeck's archives of surgery
Body weight
downin humans1
1 study
Body weight
downin humans1
Single anastomosis sleeve ileal bypass is linked with lower body weight in humans (Primary metabolic and bariatric surgery) (Mean total weight loss 33.0%).
“Mean %TWL 33.0%.”
HumansPrimary metabolic and bariatric surgery
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
Langenbeck's archives of surgery